GILEAD SCIENCES, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Gilead Sciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q3 2024.
  • Gilead Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $1.25B, a 42.5% decline year-over-year.
  • Gilead Sciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $127M, a 97.8% decline year-over-year.
  • Gilead Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $5.67B, a 23.4% increase from 2022.
  • Gilead Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $4.59B, a 26.2% decline from 2021.
  • Gilead Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $6.23B, a 4961% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $127M $1.25B -$927M -42.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.05B $1.61B +$569M +54.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $485M -$4.17B -$5.18B -513% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $5.67B $1.43B -$210M -12.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $5.88B $2.18B +$391M +21.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $5.48B $1.05B -$99M -8.65% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $5.58B $1.01B +$991M +5216% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $4.59B $1.64B +$1.26B +329% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $3.33B $1.79B -$803M -31% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $4.14B $1.14B -$378M -24.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $4.52B $19M -$1.71B -98.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $6.23B $382M -$1.17B -75.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $7.39B $2.59B +$2.23B +620% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $5.16B $1.52B +$4.86B Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $301M $1.73B +$178M +11.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $123M $1.55B -$1.15B -42.5% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 $1.27B $360M +$1.53B Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$257M -$3.34B -$5.22B -278% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $4.96B $1.55B -$424M -21.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $5.39B $2.7B +$2.69B Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $2.69B -$1.17B -$3.26B -156% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 $5.96B $1.88B +$63M +3.47% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 $5.89B $1.98B +$437M +28.4% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 $5.46B $3M* +$3.87B Oct 1, 2018 Dec 31, 2018 10-K 2020-02-25
Q3 2018 $1.59B $2.1B -$621M -22.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-25
Q2 2018 $2.21B $1.82B -$1.26B -40.9% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-25
Q1 2018 $3.46B $1.54B -$1.16B -43.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-25
Q4 2017 $4.63B -$3.87B -$6.97B -224% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 $11.6B $2.72B -$612M -18.4% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-26
Q2 2017 $12.2B $3.07B -$424M -12.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-26
Q1 2017 $12.6B $2.7B -$864M -24.2% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-26
Q4 2016 $13.5B $3.11B -$1.58B -33.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 $15.1B $3.33B -$1.27B -27.6% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-27
Q2 2016 $16.3B $3.5B -$995M -22.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-27
Q1 2016 $17.3B $3.57B -$767M -17.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-27
Q4 2015 $18.1B $4.68B +$1.2B +34.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-27
Q3 2015 $16.9B $4.6B +$1.87B +68.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-27
Q2 2015 $15B $4.49B +$836M +22.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-27
Q1 2015 $14.2B $4.33B +$2.11B +94.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-27
Q4 2014 $12.1B $3.49B +$2.7B +341% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-24
Q3 2014 $9.41B $2.73B +$1.94B +246% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-24
Q2 2014 $7.46B $3.66B +$2.88B +373% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-24
Q1 2014 $4.58B $2.23B +$1.51B +208% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-24
Q4 2013 $3.08B $791M +$28.5M +3.73% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-25
Q3 2013 $3.05B $789M +$113M +16.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-25
Q2 2013 $2.93B $773M +$61.4M +8.63% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-25
Q1 2013 $2.87B $722M +$280M +63.4% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-25
Q4 2012 $2.59B $763M +$97.4M +14.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-25
Q3 2012 $2.49B $676M +$234M +52.8% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-25
Q2 2012 $2.26B $712M -$34.7M -4.65% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-25
Q1 2012 $2.3B $442M -$209M -32.1% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-25
Q4 2011 $2.5B $665M +$35.7M +5.68% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-27
Q3 2011 $2.47B $442M -$263M -37.3% Jul 1, 2011 Sep 30, 2011 10-Q 2013-05-08
Q2 2011 $2.73B $746M +$34.2M +4.8% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-27
Q1 2011 $2.7B $651M -$204M -23.8% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-27
Q4 2010 $2.9B $629M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-23
Q3 2010 $705M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-23
Q2 2010 $712M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-23
Q1 2010 $855M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.